StockData
Imunon, Inc. logo

Imunon, Inc. (IMNN) stock

IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.59−0.04 (-5.56%)

Close on Nov 16, 2026Market cap $3.33MP/E –Yield –

Earnings

Imunon's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 30, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
-$0.64
-$1.16 a year earlier
Latest guidance
Issued
Nov 14, 2022 · 1 item

Quarterly results

Revenue and earnings per share from each of Imunon's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 30, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 12, 2026before the open––-$0.64Release
Q1 FY2026ended Mar 31, 2026May 12, 2026before the open––-$0.84Release
Q4 FY2025ended Dec 31, 2025Mar 31, 2026before the open–––Release
Q3 FY2025ended Sep 30, 2025Nov 13, 2025before the open––-$1.16Release
Q2 FY2025ended Jun 30, 2025Aug 5, 2025before the open––-$2.15Release
Q1 FY2025ended Mar 31, 2025May 12, 2025before the open––-$0.28Release
Q4 FY2024ended Dec 31, 2024Feb 27, 2025before the open–––Release
Q3 FY2024ended Sep 30, 2024Nov 7, 2024before the open––-$0.34Release
Q2 FY2024ended Jun 30, 2024Aug 14, 2024before the open––-$0.51Release
Q1 FY2024ended Mar 31, 2024May 13, 2024before the open––-$0.52Release
Q4 FY2023ended Dec 31, 2023Mar 28, 2024before the open–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

No open guidance: every period Imunon guided for has been reported

Guidance history

Every forecast Imunon put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 14, 2022projected cash utilizationFY2022$5.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Imunon filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. News
  3. Update
  4. Results
  5. Update
  6. Results
  7. Results
  8. News
  9. Results
  10. Results
  11. News
  12. Update
  13. News
  14. Results
  15. News

See a number that looks wrong?